Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.35 |
| ▸ | CPT1A | P50416 | 2/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | CPT2 | P23786 | 1/20 | 0.34 |
| ▸ | PRKDC | P78527 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL426258 | 0.99 | FFAR4 (0.38) | FFAR4HSD17B10PPARDMRGPRX4CPT1A | |
| Hydrochloric Acid SCHEMBL429209 | 0.95 | FFAR4 (0.38) | FFAR4HSD17B10PPARDMRGPRX4CPT1A | |
| SCHEMBL5733075 | 0.93 | DGAT1 (0.40) | FFAR4HSD17B10PPARDDGAT1TSHR | |
| Hydrochloric Acid SCHEMBL423865 | 0.92 | DGAT1 (0.40) | FFAR4HSD17B10PPARDDGAT1TSHR | |
| Hydrochloric Acid SCHEMBL428939 | 0.89 | KMT2A (0.34) | HSD17B10 | |
| Hydrochloric Acid SCHEMBL426929 | 0.89 | NPY1R (0.34) | CPT1ACPT2 | |
| SCHEMBL4137241 | 0.89 | FFAR4 (0.34) | FFAR4MRGPRX4CPT1ACPT2 | |
| Hydrochloric Acid SCHEMBL426257 | 0.88 | FFAR4 (0.34) | FFAR4MRGPRX4CPT1ACPT2 | |
| Hydrochloric Acid SCHEMBL424874 | 0.85 | HSD17B10 (0.41) | HSD17B10PPARDMRGPRX4DGAT1PRKDC | |
| SCHEMBL10253090 | 0.84 | SCN9A (0.34) | FFAR4MRGPRX4CPT1ACPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036444-A1 | 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036444-A1 | 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor | GTF3C5, ZC3HAV1, POLI | FFAR4 4607/4885HSD17B10 905/4885PPARD 1645/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.